These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38960243)

  • 1. Synthesis, biological evaluation, and molecular modelling of substituted thiazolyl thiourea derivatives: A new class of prolyl oligopeptidase inhibitors.
    Naseem S; Oneto A; Ullah S; Fatima S; Mali SN; Jawarkar RD; Khan A; Alharthy RD; Kashtoh H; Al-Harrasi A; Shafiq Z; Boshta NM
    Int J Biol Macromol; 2024 Aug; 275(Pt 1):133571. PubMed ID: 38960243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of novel chemical scaffolds targeting prolyl oligopeptidase for neurological therapeutics.
    Kumar R; Parameswaran S; Bavi R; Baek A; Son M; Rampogu S; Park C; Lee G; Zeb A; Parate S; Rana RM; Lee KW
    J Mol Graph Model; 2019 May; 88():92-103. PubMed ID: 30665156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel benzimidazole derivatives as effective inhibitors of prolyl oligopeptidase: synthesis,
    Shakoor A; Alam A; Jan F; Khan M; Ali M; Ullah S; Khan A; AlAsmari AF; Alasmari F; Al-Ghafri A; Al-Harrasi A
    Future Med Chem; 2024 Jan; 16(1):43-58. PubMed ID: 38054466
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of prolyl oligopeptidase with a synthetic unnatural dipeptide.
    Racys DT; Rea D; Fülöp V; Wills M
    Bioorg Med Chem; 2010 Jul; 18(13):4775-82. PubMed ID: 20627594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors.
    Babkova K; Korabecny J; Soukup O; Nepovimova E; Jun D; Kuca K
    Future Med Chem; 2017 Jun; 9(10):1015-1038. PubMed ID: 28632451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New compounds identified through in silico approaches reduce the α-synuclein expression by inhibiting prolyl oligopeptidase in vitro.
    Kumar R; Bavi R; Jo MG; Arulalapperumal V; Baek A; Rampogu S; Kim MO; Lee KW
    Sci Rep; 2017 Sep; 7(1):10827. PubMed ID: 28883518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP).
    Haffner CD; Diaz CJ; Miller AB; Reid RA; Madauss KP; Hassell A; Hanlon MH; Porter DJ; Becherer JD; Carter LH
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4360-3. PubMed ID: 18606544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constrained peptidomimetics reveal detailed geometric requirements of covalent prolyl oligopeptidase inhibitors.
    Lawandi J; Toumieux S; Seyer V; Campbell P; Thielges S; Juillerat-Jeanneret L; Moitessier N
    J Med Chem; 2009 Nov; 52(21):6672-84. PubMed ID: 19888757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel prolyl oligopeptidase inhibitors from resin of Boswella papyrifera (Del.) Hochst. and their mechanism: Virtual and biochemical studies.
    Khan A; Waqas M; Khan M; Halim SA; Rehman NU; Al-Harrasi A
    Int J Biol Macromol; 2022 Jul; 213():751-767. PubMed ID: 35679958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and activity of pyrrolidinyl- and thiazolidinyl-dipeptide derivatives as inhibitors of the Tc80 prolyl oligopeptidase from Trypanosoma cruzi.
    Joyeau R; Maoulida C; Guillet C; Frappier F; Teixeira AR; Schrével J; Santana J; Grellier P
    Eur J Med Chem; 2000 Feb; 35(2):257-66. PubMed ID: 10758287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating the selectivity of inhibitors for prolyl oligopeptidase inhibitors and fibroblast activation protein-α for different indications.
    Plescia J; Hédou D; Pousse ME; Labarre A; Dufresne C; Mittermaier A; Moitessier N
    Eur J Med Chem; 2022 Oct; 240():114543. PubMed ID: 35797897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel small molecule non-peptidomimetic inhibitor for prolyl oligopeptidase through
    Shrivastava A; Srivastava S; Malik R; Alam MM; Shaqiquzamman M; Akhter M
    J Biomol Struct Dyn; 2020 Mar; 38(5):1292-1305. PubMed ID: 30929611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting inhibition of fibroblast activation protein-α and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments.
    Christiansen VJ; Jackson KW; Lee KN; Downs TD; McKee PA
    Neoplasia; 2013 Apr; 15(4):348-58. PubMed ID: 23555181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Human Prolyl Oligopeptidase Activity by the Cyclotide Psysol 2 Isolated from Psychotria solitudinum.
    Hellinger R; Koehbach J; Puigpinós A; Clark RJ; Tarragó T; Giralt E; Gruber CW
    J Nat Prod; 2015 May; 78(5):1073-82. PubMed ID: 25894999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal Structure and Conformational Dynamics of Pyrococcus furiosus Prolyl Oligopeptidase.
    Ellis-Guardiola K; Rui H; Beckner RL; Srivastava P; Sukumar N; Roux B; Lewis JC
    Biochemistry; 2019 Mar; 58(12):1616-1626. PubMed ID: 30786206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dicarboxylic acid azacycle l-prolyl-pyrrolidine amides as prolyl oligopeptidase inhibitors and three-dimensional quantitative structure-activity relationship of the enzyme-inhibitor interactions.
    Jarho EM; Wallén EA; Christiaans JA; Forsberg MM; Venäläinen JI; Männistö PT; Gynther J; Poso A
    J Med Chem; 2005 Jul; 48(15):4772-82. PubMed ID: 16033257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dicarboxylic acid bis(L-prolyl-pyrrolidine) amides as prolyl oligopeptidase inhibitors.
    Wallén EA; Christiaans JA; Forsberg MM; Venäläinen JI; Männistö PT; Gynther J
    J Med Chem; 2002 Sep; 45(20):4581-4. PubMed ID: 12238937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural analysis of prolyl oligopeptidases using molecular docking and dynamics: insights into conformational changes and ligand binding.
    Kaushik S; Sowdhamini R
    PLoS One; 2011; 6(11):e26251. PubMed ID: 22132071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biological role of prolyl oligopeptidase and the procognitive potential of its peptidic inhibitors from food proteins.
    Taraszkiewicz A; Sinkiewicz I; Sommer A; Staroszczyk H
    Crit Rev Food Sci Nutr; 2024; 64(19):6567-6580. PubMed ID: 36798052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active-Site-Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational Dynamics.
    López A; Herranz-Trillo F; Kotev M; Gairí M; Guallar V; Bernadó P; Millet O; Tarragó T; Giralt E
    Chembiochem; 2016 May; 17(10):913-7. PubMed ID: 26918396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.